4DMedical signs distribution agreement with Blackford

4DMedical Limited (ASX: $4DX) has signed an agreement with Blackford Analysis Inc to distribute Imbio's medical imaging AI solutions. This partnership expands 4DMedical's distribution network across the three leading medical imaging AI marketplaces, including Nuance, Aidoc, and now Blackford.

4DMedical MD/CEO and Founder Andreas Fouras's commentary on the partnership with Blackford

We are incredibly excited to be partnering with Blackford as a distributor of Imbio's AI solutions. This deal positions our Imbio products with a comprehensive distribution network across the three leading platforms connecting AI providers with hospitals, doctors and their patients. With established contracts and recurring revenue, five new technologies in clinical use, and a very strong product pipeline, Imbio has incredible operational momentum in its own right. We are particularly excited by the opportunities for Imbio technology to provide solutions for the VA, and look forward to sharing further progress over the coming weeks and months.

4DMedical's partnership with Blackford and future outlook

4DMedical Limited (ASX: $4DX) has expanded its distribution network by partnering with Blackford Analysis Inc to distribute Imbio's medical imaging AI solutions. This agreement positions 4DMedical with partnerships across the three leading medical imaging AI marketplaces, enhancing its reach and accessibility. The company's MD/CEO and Founder, Andreas Fouras, expressed excitement about the comprehensive distribution network and highlighted the operational momentum of Imbio's products. With established contracts, recurring revenue, and a strong product pipeline, 4DMedical anticipates further progress and opportunities for Imbio technology, particularly in providing solutions for the VA.